Search results
CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
Reuters via Yahoo News· 2 years agoBERLIN (Reuters) -CureVac has filed a patent lawsuit in Germany against BioNTech over its use of...
Analyst Forecasts Just Became More Bearish On CureVac N.V. (NASDAQ:CVAC)
Simply Wall St. via Yahoo Finance· 1 year agoOne thing we could say about the analysts on CureVac N.V. (NASDAQ:CVAC) - they aren't optimistic,...
CureVac to cut costs in restructuring
BioPharma Dive via Yahoo Finance· 1 month agoThe mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
Benzinga via Yahoo Finance· 6 months agoA German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against...
Why CureVac Stock Leaped 12% Higher Today
Motley Fool· 12 months agoA successful cancer drug or vaccine is the holy grail of biotech companies. On news that its cancer-vaccine candidate had reached an important new stage...
Why CureVac's Shares Jumped on Tuesday
Motley Fool· 1 year agoShares of CureVac (NASDAQ: CVAC) rose as much as 19.1% on Tuesday. Despite the rise, CureVac is down more than 59% over the past year, though it is now...
7 Biotech Stocks That Will Make You Rich in 10 Years
InvestorPlace via Yahoo Finance· 1 year agoIf you have the patience to go through wild undulations, then you may be a candidate for biotech stocks that will make you rich in 10 years. Even among...
10 Notable Market Movers to Watch on Wednesday
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will take a look at the 10 notable market movers to watch on Wednesday. If you want to see some other stocks making big moves today,...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 2 weeks agoSemafor Signals Supported by Insights from The Financial Times, Bloomberg, and The Associated Press The News As the United States confirmed a second...
Company News for Jan 11, 2023
Zacks via Yahoo Finance· 1 year agoShares of TD SYNNEX Corp. SNX surged 4.7% after reporting fourth quarter fiscal 2022 adjusted earnings per share of $3.44, surpassing the Zacks Consensus...